Green Cross Holdings

Green Cross Holdings

Green Cross Holdings was founded in 1967 as the parent of the Green Cross Group. Heo Il-sup serves as chairman. The structure centers on control of pharmaceutical manufacturing and related healthcare businesses rather than external fund commitments. The firm deploys capital through direct ownership of subsidiaries and selective venture positions. Asset classes include listed equities in biotechnology, industrial manufacturing sites, and minority stakes in early-stage companies. Confirmed holdings include GC Biopharma, GC Cell, GC Wellbeing, and limited partner positions in Humanscape and Red Blue. Geographic focus remains South Korea with one co-founded US biotechnology entity, Artiva Biotherapeutics. Assets total 873 million USD. The group operates six specialized production and research facilities in Yongin, Hwasun, Ochang, and Eumseong. September 2024: Spoke at DeSci Seoul 2024 on R&D Leveraging Blockchain and Decentralized Science. Four foundations support health and education causes, including the MOGAM Institute for Biomedical Research established in 1984. Ownership passes through family members with Heo Yong-jun as CEO of the holding company and Heo Eun-chul leading the main biopharma subsidiary. This integrated operating-company model distinguishes the entity from pure financial investors.